Intangible Assets

Renexxion’s moat from intangible assets appears limited because the provided metrics show negative ROIC and ROCE, which indicates any proprietary know-how is not yet translating into durable excess returns versus peers.

Without disclosed evidence of strong patents, regulatory exclusivity, or brand-led pricing power in the supplied data, the company looks more like a product participant than a structurally differentiated incumbent versus peers.

Compared with peers that can monetize protected IP or entrenched clinical/regulatory franchises, RENX appears to have weaker evidence of asset-based pricing power and retention.

The absence of 5-year profitability and margin history in the provided data reduces confidence that intangible assets are sustaining margins over a full cycle versus peers.

Switching Costs

The negative ROIC and weak capital efficiency suggest customers are not yet locked in by high switching costs that would support durable pricing power versus peers.

No provided evidence shows workflow integration, data migration friction, or contractual lock-in strong enough to make RENX meaningfully harder to replace than peer alternatives.

Compared with peers that benefit from embedded platforms or recurring usage tied to mission-critical operations, RENX’s switching-cost profile looks less proven and more replaceable.

The negative cash conversion cycle alone does not demonstrate customer lock-in, so retention durability remains unproven in the supplied metrics.

Network Effects

The supplied data do not show user-to-user, data, or ecosystem feedback loops that would create self-reinforcing demand versus peers.

Negative profitability and low asset turnover are inconsistent with a scaled network effect that is already converting adoption into durable monetization.

Compared with peer platforms where each additional participant increases value for others, RENX shows no evidence of such compounding advantage in the provided metrics.

Absent clear network-driven retention or pricing power, the moat contribution from network effects appears weak.

Cost Advantage

RENX’s negative ROIC and ROCE indicate it is not currently converting its cost base into superior returns, which argues against a durable cost advantage versus peers.

Asset turnover of 0.39x suggests relatively low operating efficiency, so the company does not appear to have a structural cost edge that would pressure peer pricing.

Compared with peers that can leverage scale procurement, manufacturing, or distribution efficiencies, RENX’s provided metrics do not show a clear unit-cost advantage.

The negative cash conversion cycle may help working capital, but it is not enough on its own to establish a lasting cost moat.

Efficient Scale

The provided data do not show evidence that RENX operates in a niche with enough scale economics to deter peer entry or sustain above-peer margins.

Negative returns on invested capital suggest any scale benefits are not yet strong enough to create a durable barrier to competition versus peers.

Compared with peers in tightly constrained markets, RENX does not appear to have demonstrated efficient-scale protection in the supplied metrics.

The absence of stable long-run margin data makes it difficult to argue that scale is limiting competition or preserving pricing power over 5–10 years.

Overall Score

RENX shows limited evidence of durable moat strength versus peers, with no clear proof in the supplied data of strong intangible assets, switching costs, network effects, or cost advantage, and the overall profile is held down by negative ROIC/ROCE and weak operating efficiency.